Share 'What can we do NOW to get next trials for SMT C1100 (utrophin upgregulator) in the US in the future?'
Considering that BioMarin has scrapped their similar program, and that Dr. Davies is at Oxford, I'm very concerned that the next phase of trials for SMT C1100 will happen in Europe or elsewhere outside the U.S.
In my opinion when this happens the FDA uses it as an excuse to take "wait and see" approach and for those of us with boys in…
You can share this discussion in two ways…
Share this link:
Send it with your computer's email program: Email this